文献速递甲状腺与颈部外科围术期管理与 ERAS

肾移植前甲状旁腺切除术降低移植物失败风险

Parathyroidectomy prior to kidney transplant decreases graft failure.
PubMed 文献 · Surgery · 2016-11-15

单中心回顾性研究分析2005至2014年913例成人肾移植患者,发现术前未纠正的尿毒症性甲状旁腺功能亢进与术后第一年并发症相关(OR 1.44),术前甲状旁腺激素≥6倍正常上限与移植物失败相关(P<.05),而移植前甲状旁腺切除术与移植物失败风险降低相关(OR 0.547)。

要点

  • 术前未纠正的尿毒症性甲旁亢与肾移植术后第一年并发症风险升高相关(OR 1.44)。
  • 术前甲状旁腺激素≥6倍正常上限与移植后移植物失败相关(P<.05)。
  • 移植前甲状旁腺切除术与移植物失败风险降低相关(OR 0.547)。

核心结论

  • 肾移植前甲状旁腺切除术可降低移植后移植物失败风险,可能使血清甲状旁腺激素降至当前KDIGO指南目标范围的患者获益。

主要发现

  • 移植后1年移植物存活率为97.8%。
  • 462例(50.6%)患者术前存在未纠正的尿毒症性甲状旁腺功能亢进,与移植后第一年并发症相关(OR 1.44;95%CI 1.11-1.87),但与移植肾功能延迟恢复或移植物失败无统计学关联。
  • 术前甲状旁腺激素≥6倍正常上限与移植后移植物失败相关(P<.05)。
  • 57例(6.2%)患者行移植前甲状旁腺切除术,与移植物失败风险降低相关(OR 0.547;95%CI 0.327-0.913),但与移植肾功能延迟恢复或并发症无统计学显著关联。

关键数值与推荐

  • 当前KDIGO指南推荐肾移植前维持甲状旁腺激素≤9倍正常上限。
  • 术前甲状旁腺激素≥6倍正常上限与移植后移植物失败相关(P<.05)。
  • 移植前甲状旁腺切除术与移植物失败风险降低相关(OR 0.547;95%CI 0.327-0.913)。

临床怎么用

  • 对肾移植候选者应评估血清甲状旁腺激素水平,术前未纠正的尿毒症性甲旁亢与术后并发症风险升高相关。
  • 术前甲状旁腺激素≥6倍正常上限者移植物失败风险增加,可考虑移植前甲状旁腺切除术以降低失败风险。
  • 移植前甲状旁腺切除术可能使甲状旁腺激素降至KDIGO指南目标范围的患者获益。

局限性

  • 回顾性单中心设计。
  • 未报告甲状旁腺切除术的具体指征及手术时机选择标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Uncorrected uremic hyperparathyroidism is associated with delayed graft function after kidney transplantation. The current guidelines of the Kidney Disease Improving Global Outcomes recommend maintaining parathyroid hormone ≤9x normal in patients pre-kidney transplantation. This study explores the effect of increased levels of serum parathyroid hormone and preoperative parathyroidectomy on outcomes after kidney transplantation. METHODS: A retrospective review was performed of adult patients who underwent kidney transplantation between January 1, 2005, and December 31, 2014, at a single institution. Biochemistries and outcomes were analyzed pre-kidney transplantation and at 30 days, 6 months, and 1 year post-kidney transplantation. RESULTS: A total of 913 patients underwent kidney transplantation from 2005-2014. Graft survival 1 year post-kidney transplantation was 97.8%. Overall, 462 (50.6%) patients had a pre-kidney transplantation diagnosis of uncorrected uremic hyperparathyroidism, which was associated with complications in the first year post-kidney transplantation (odds ratio 1.44; 95% confidence interval, 1.11-1.87); no statistical association with delayed graft function or graft failure was detected. Pre-kidney transplantation parathyroid hormone ≥6x normal was associated with post-kidney transplantation graft failure (P < .05). A total of 57 (6.2%) patients underwent pre-kidney transplantation parathyroidectomy, which was associated with lesser risk of graft failure (odds ratio: 0.547; 95% confidence interval, 0.327-0.913), but no statistically significant association with delayed graft function or complications were detected. CONCLUSION: Pre-kidney transplantation parathyroidectomy decreases post-kidney transplantation graft failure and may benefit patients whose serum parathyroid hormone levels decrease into the target range of current Kidney Disease Improving Global Outcomes guidelines.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Callender GG, Malinowski J, Javid M, et al. Parathyroidectomy prior to kidney transplant decreases graft failure. Surgery. 2016. PMID: 27863776. doi:10.1016/j.surg.2016.10.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。